Koninklijke Philips (NYSE:PHG) Given Average Rating of “Moderate Buy” by Analysts

Shares of Koninklijke Philips (NYSE:PHG) have been given an average rating of “Moderate Buy” by the five research firms that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company.

PHG has been the topic of a number of research reports. StockNews.com raised Koninklijke Philips from a “hold” rating to a “buy” rating in a research note on Saturday, March 8th. UBS Group raised Koninklijke Philips from a “neutral” rating to a “buy” rating in a report on Thursday, February 20th. BNP Paribas raised Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research report on Tuesday, February 25th. Finally, Sanford C. Bernstein raised Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, March 18th.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Colonial Trust Co SC raised its stake in shares of Koninklijke Philips by 724.0% during the 4th quarter. Colonial Trust Co SC now owns 1,409 shares of the technology company’s stock worth $36,000 after purchasing an additional 1,238 shares during the period. Bessemer Group Inc. raised its position in Koninklijke Philips by 2,935.4% in the first quarter. Bessemer Group Inc. now owns 1,973 shares of the technology company’s stock worth $51,000 after acquiring an additional 1,908 shares during the period. Wilmington Savings Fund Society FSB bought a new stake in Koninklijke Philips in the third quarter worth about $54,000. Farther Finance Advisors LLC boosted its stake in Koninklijke Philips by 37.1% in the fourth quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company’s stock valued at $54,000 after acquiring an additional 582 shares during the last quarter. Finally, Whipplewood Advisors LLC bought a new position in shares of Koninklijke Philips during the 4th quarter valued at approximately $55,000. Hedge funds and other institutional investors own 13.67% of the company’s stock.

Koninklijke Philips Stock Performance

Shares of Koninklijke Philips stock opened at $24.71 on Tuesday. The stock has a market cap of $23.23 billion, a price-to-earnings ratio of -29.42, a P/E/G ratio of 0.82 and a beta of 0.81. Koninklijke Philips has a twelve month low of $19.90 and a twelve month high of $32.91. The company’s fifty day moving average is $25.15 and its 200 day moving average is $26.49. The company has a quick ratio of 0.74, a current ratio of 1.23 and a debt-to-equity ratio of 0.59.

Koninklijke Philips (NYSE:PHG) last released its quarterly earnings data on Wednesday, February 19th. The technology company reported $0.54 earnings per share for the quarter, missing the consensus estimate of $0.55 by ($0.01). The company had revenue of $5.38 billion during the quarter, compared to the consensus estimate of $5.10 billion. Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. Sell-side analysts forecast that Koninklijke Philips will post 1.63 EPS for the current year.

Koninklijke Philips Cuts Dividend

The firm also recently announced an annual dividend, which will be paid on Friday, June 6th. Stockholders of record on Tuesday, May 13th will be issued a $0.886 dividend. This represents a dividend yield of 2.9%. The ex-dividend date of this dividend is Tuesday, May 13th. Koninklijke Philips’s dividend payout ratio is presently -89.29%.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.